Abiomed continues to strengthen its intellectual property, now holds more than 1,000 patents

Danvers, mass.--(business wire)--abiomed (nasdaq: abmd) announces it has surpassed more than 1,000 patents worldwide, with more than 850 additional patents pending. abiomed's robust intellectual property portfolio protects its current and future pump and catheter designs, along with other product components such as motors, cannulas, sensors, software, and access devices. the portfolio also protects manufacturing processes and future artificial intelligence algorithms. abiomed is recognized as a
ABMD Ratings Summary
ABMD Quant Ranking